Advertisement

Research Article Free access | 10. 1172/JCI2169 VSports.

"VSports注册入口" Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury.

Y Cheng, M Deshmukh, A D'Costa, J A Demaro, J M Gidday, A Shah, Y Sun, M F Jacquin, E M Johnson, and D M Holtzman

Department of Neurology, Washington University School of Medicine, St VSports app下载. Louis, Missouri 63110, USA.

Find articles by Cheng, Y V体育官网. in: PubMed | Google Scholar .

Department of Neurology, Washington University School of Medicine, St VSports手机版. Louis, Missouri 63110, USA.

Find articles by Deshmukh, M V体育安卓版. in: PubMed | Google Scholar .

Department of Neurology, Washington University School of Medicine, St V体育ios版. Louis, Missouri 63110, USA.

Find articles by D'Costa, A VSports最新版本. in: PubMed | Google Scholar .

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA V体育平台登录.

Find articles by Demaro, J. in: PubMed | Google Scholar VSports注册入口.

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA V体育官网入口.

Find articles by Gidday, J. in: PubMed | Google Scholar

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Find articles by Shah, A. in: PubMed | Google Scholar

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Find articles by Sun, Y. in: PubMed | Google Scholar

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Find articles by Jacquin, M. in: PubMed | Google Scholar

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Find articles by Johnson, E. in: PubMed | Google Scholar

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Find articles by Holtzman, D. in: PubMed | Google Scholar

Published May 1, 1998 - More info

Published in Volume 101, Issue 9 on May 1, 1998
J Clin Invest. 1998;101(9):1992–1999. https://doi.org/10.1172/JCI2169.
© 1998 The American Society for Clinical Investigation
Published May 1, 1998 - Version history
View PDF
Abstract

Programmed cell death (apoptosis) is a normal process in the developing nervous system. Recent data suggest that certain features seen in the process of programmed cell death may be favored in the developing versus the adult brain in response to different brain injuries. In a well characterized model of neonatal hypoxia-ischemia, we demonstrate marked but delayed cell death in which there is prominent DNA laddering, TUNEL-labeling, and nuclei with condensed chromatin. Caspase activation, which is required in many cases of apoptotic cell death, also followed a delayed time course after hypoxia-ischemia. Administration of boc-aspartyl(OMe)-fluoromethylketone, a pan-caspase inhibitor, was significantly neuroprotective when given by intracerebroventricular injection 3 h after cerebral hypoxia-ischemia. In addition, systemic injections of boc-aspartyl(OMe)-fluoromethylketone also given in a delayed fashion, resulted in significant neuroprotection. These findings suggest that caspase inhibitors may be able to provide benefit over a prolonged therapeutic window after hypoxic-ischemic events in the developing brain, a major contributor to static encephalopathy and cerebral palsy.

Version history
  • Version 1 (May 1, 1998): No description
Advertisement
Advertisement